178 related articles for article (PubMed ID: 27605462)
1. A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies.
Quinn CT; Paniagua MC; DiNello RK; Panchal A; Geisberg M
Br J Haematol; 2016 Nov; 175(4):724-732. PubMed ID: 27605462
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test.
Steele C; Sinski A; Asibey J; Hardy-Dessources MD; Elana G; Brennan C; Odame I; Hoppe C; Geisberg M; Serrao E; Quinn CT
Am J Hematol; 2019 Jan; 94(1):39-45. PubMed ID: 30290004
[TBL] [Abstract][Full Text] [Related]
3. HemoTypeSC, a low-cost point-of-care testing device for sickle cell disease: Promises and challenges.
Nnodu O; Isa H; Nwegbu M; Ohiaeri C; Adegoke S; Chianumba R; Ugwu N; Brown B; Olaniyi J; Okocha E; Lawson J; Hassan AA; Diaku-Akinwumi I; Madu A; Ezenwosu O; Tanko Y; Kangiwa U; Girei A; Israel-Aina Y; Ladu A; Egbuzu P; Abjah U; Okolo A; Akbulut-Jeradi N; Fernandez M; Piel FB; Adekile A
Blood Cells Mol Dis; 2019 Sep; 78():22-28. PubMed ID: 30773433
[TBL] [Abstract][Full Text] [Related]
4. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease.
Nguyen-Khoa T; Mine L; Allaf B; Ribeil JA; Remus C; Stanislas A; Gauthereau V; Enouz S; Kim JS; Yang X; Gluckman E; Beaudeux JL; Munnich A; Girot R; Cavazzana M
Ann Biol Clin (Paris); 2018 Aug; 76(4):416-420. PubMed ID: 29976532
[TBL] [Abstract][Full Text] [Related]
5. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India.
Mukherjee MB; Colah RB; Mehta PR; Shinde N; Jain D; Desai S; Dave K; Italia Y; Raicha B; Serrao E
Am J Clin Pathol; 2020 Jan; 153(1):82-87. PubMed ID: 31433854
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of high performance liquid chromatography (HPLC) pattern and prevalence of beta-thalassaemia trait among sickle cell disease patients in Lagos, Nigeria.
Adeyemo T; Ojewunmi O; Oyetunji A
Pan Afr Med J; 2014; 18():71. PubMed ID: 25400838
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a Portable Haemoglobin Metre Performance in Children with Sickle Cell Disease and Implications for Healthcare in Resource-poor Settings.
Olatunya OS; Olu-Taiwo A; Ogundare EO; Oluwayemi IO; Olaleye AO; Fadare JO; Adekoya-Benson T; Fatunla O; Agaja OT; Omoniyi E; Oluwadiya KS
J Trop Pediatr; 2016 Aug; 62(4):316-23. PubMed ID: 26995011
[TBL] [Abstract][Full Text] [Related]
8. Potential of point of care tests for newborn screening for sickle cell disease: Evaluation of HemotypeSC™ and sickle SCAN® in Tanzania.
Christopher H; Josephat E; Kaywanga F; Saul S; Mshana I; Kunambi P; Nasser A; Chamba C; Makani J; Nkya S
Int J Lab Hematol; 2022 Oct; 44(5):959-965. PubMed ID: 35775883
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Accuracy of HemotypeSC as a Point-of-Care Testing Device for Sickle Cell Disease: Findings from a Southwestern State in Nigeria and Implications for Patient Care in Resource-Poor Settings of sub-Saharan Africa.
Olatunya OS; Albuquerque DM; Fagbamigbe AF; Faboya OA; Ajibola AE; Babalola OA; Adebisi AO; Falusi AG; Adekile A; Costa FF
Glob Pediatr Health; 2021; 8():2333794X211016789. PubMed ID: 34046518
[TBL] [Abstract][Full Text] [Related]
10. Screening for sickle cell disease on dried blood: a new approach evaluated on 27,000 Belgian newborns.
Boemer F; Vanbellinghen JF; Bours V; Schoos R
J Med Screen; 2006; 13(3):132-6. PubMed ID: 17007654
[TBL] [Abstract][Full Text] [Related]
11. Novel test method (sickle confirm) to differentiate sickle cell anemia from sickle cell trait for potential use in developing countries.
Randolph TR; Wheelhouse J
Clin Lab Sci; 2012; 25(1):26-34. PubMed ID: 22458046
[TBL] [Abstract][Full Text] [Related]
12. Preliminary Evaluation of a Point-of-Care Testing Device (SickleSCAN™) in Screening for Sickle Cell Disease.
Nwegbu MM; Isa HA; Nwankwo BB; Okeke CC; Edet-Offong UJ; Akinola NO; Adekile AD; Aneke JC; Okocha EC; Ulasi T; Abjah U; Ugwu NI; Okolo AA; Madu A; Emodi I; Girei A; Balogun TM; Diaku-Akinwumi IN; Ohiaeri C; Brown BJ; Olaniyi JA; Hassan A; Awwalu S; Okoh DA; Nnodu OE
Hemoglobin; 2017 Mar; 41(2):77-82. PubMed ID: 28617057
[TBL] [Abstract][Full Text] [Related]
13. Using dried blood spot on HemoTypeSC™, a new frontier for newborn screening for sickle cell disease in Nigeria.
Okeke CO; Chianumba RI; Isa H; Asala S; Nnodu OE
Front Genet; 2022; 13():1013858. PubMed ID: 36386848
[No Abstract] [Full Text] [Related]
14. Chromatographic measurements of hemoglobin A2 in blood samples that contain sickle hemoglobin.
Shokrani M; Terrell F; Turner EA; Aguinaga MD
Ann Clin Lab Sci; 2000 Apr; 30(2):191-4. PubMed ID: 10807164
[TBL] [Abstract][Full Text] [Related]
15. Determination of birth prevalence of sickle cell disease using point of care test HemotypeSC™ at Rundu Hospital, Namibia.
Mano RM; Kuona P; Misihairabgwi JM
BMC Pediatr; 2024 May; 24(1):323. PubMed ID: 38730340
[TBL] [Abstract][Full Text] [Related]
16. Validation of a novel point of care testing device for sickle cell disease.
Kanter J; Telen MJ; Hoppe C; Roberts CL; Kim JS; Yang X
BMC Med; 2015 Sep; 13():225. PubMed ID: 26377572
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous point-of-care detection of anemia and sickle cell disease in Tanzania: the RAPID study.
Smart LR; Ambrose EE; Raphael KC; Hokororo A; Kamugisha E; Tyburski EA; Lam WA; Ware RE; McGann PT
Ann Hematol; 2018 Feb; 97(2):239-246. PubMed ID: 29147848
[TBL] [Abstract][Full Text] [Related]
18. Sickle solubility test to screen for sickle cell trait: what's the harm?
Tubman VN; Field JJ
Hematology Am Soc Hematol Educ Program; 2015; 2015():433-5. PubMed ID: 26637754
[No Abstract] [Full Text] [Related]
19. Implementing newborn screening for sickle cell disease as part of immunisation programmes in Nigeria: a feasibility study.
Nnodu OE; Sopekan A; Nnebe-Agumadu U; Ohiaeri C; Adeniran A; Shedul G; Isa HA; Owolabi O; Chianumba RI; Tanko Y; Iyobosa JH; Adekile AD; Olopade OI; Piel FB
Lancet Haematol; 2020 Jul; 7(7):e534-e540. PubMed ID: 32589979
[TBL] [Abstract][Full Text] [Related]
20. Description of criteria for near miss in high-complexity obstetric population with sickle cell anemia: an observational study.
Burgos Luna JM; Páez Rúa DM; Ruiz Ordoñez I; Fernández PA; Escobar Vidarte MF
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):941-946. PubMed ID: 30231783
[No Abstract] [Full Text] [Related]
[Next] [New Search]
